Cross-Reactive T Cells Could Point to Broad Vaccines or Treatments for Measles, Nipah Virus

Scientists identified "cross-reactive" T cells that can recognize different paramyxovirus pathogens, which may point to the development of vaccines and therapies that can target measles, Nipah, and other paramyxovirus infections at once. The post Cross-Reactive T Cells Could Point to Broad Vaccines or Treatments for Measles, Nipah Virus appeared first on GEN - Genetic Engineering and Biotechnology News.